Search
for
Sort by
Research 511–540 of 1000+
- Are Women with Polycystic Ovary Syndrome at Increased Risk of Alzheimer Disease? Lessons from Insulin Resistance, Tryptophan and Gonadotropin Disturbances and Their Link with Amyloid-Beta Aggregation
- Metabolic Syndrome and Skin Disease: Potential Connection and Risk
- Signal detection between 5-alpha reductase inhibitors and the risk of suicidality and depression: an international pharmacovigilance analysis
- Physical attractiveness, same-sex stimuli, and male venture capitalists’ financial risk-taking
- Potential Role of Cinnamon (<i>Cinnamomum verum</i>) to Reduce the Risk of Polycystic Ovary Syndrome by Managing the Obesity: A Review
- Finasteride prescribed for hair loss consistently leads to depression. Comment on ‘Depression risk of 5-alpha reductase inhibitors: impact of active-comparator versus non-drug user control groups on risk measurement’
- Should Male Pattern Baldness Be Considered in Prostate Cancer Risk Assessment? A Systematic Review and Meta-analysis
- GLP-1 Receptor Agonists and Alopecia: A Systematic Review and Meta-analysis of Incidence, Risk, Subtypes, and Mechanisms
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
- Chemotherapy-Induced Alopecia in Breast Cancer Patients: Treatment-Specific Incidence and Risk of Persistent Hair Loss
- Androgenetic alopecia is not associated with increased incidence of cardiovascular disease risk factors: A retrospective cohort study
- Androgenetic alopecia - just a cosmetic defect or a biomarker and risk factor for systemic diseases? - literature review
- Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review
- Elucidating causal relationships of diet-derived circulating antioxidants and the risk of non-scarring alopecia: A Mendelian randomization study
- Finasteride and Dutasteride in the Treatment of Androgenetic Alopecia: Risk or Benefit?
- Gender differences of the clinical aspects and complication risks of diabetes mellitus among outpatient clinic visits, Jeddah, Saudi Arabia
- Determination of illegal adulteration of dietary supplements with synthetic hair-growth compounds by UPLC and LC-Q-TOF/MS Part A Chemistry, analysis, control, exposure & risk assessment
- Former finasteride users with sexual side effects at increased risk for depressive symptoms, suicidal thoughts
- Collider bias undermines our understanding of COVID-19 disease risk and severity
- Collider bias undermines our understanding of COVID-19 disease risk and severity
- Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors
- Molecular epidemiology of hypospadias: Review of genetic and environmental risk factors
- Sex hormone binding globulin - an important biomarker for predicting PCOS risk: A systematic review and meta-analysis
- The E211 G>A Androgen Receptor Polymorphism Is Associated with a Decreased Risk of Metastatic Prostate Cancer and Androgenetic Alopecia
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Alopecia and its association with coronary heart disease and cardiovascular risk factors: A meta-analysis
- Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome
- Genome-wide meta-analysis implicates mediators of hair follicle development and morphogenesis in risk for severe acne
- Human Leukocyte Antigen Class II Alleles Are Associated with Risk of Alopecia Areata
- Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism*